Zenflow Spring Implant and Delivery System: FDA status

Approved Approved Dec 11, 2025. Indication: benign prostatic hyperplasia first line interventional therapy. Company: Zenflow Inc.

Regulatory history

All products in the FDA Tracker

Loading today's edition…